Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. Their vaccine, Nuvaxovid, was approved in the European Union at the end of 2021 and in Canada in February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. More information...
According to PR-model, novavax.com is ranked 248,023rd in multilingual Wikipedia, in particular this website is ranked 182,203rd in English Wikipedia.
The website is placed before ohlonemonitor.com and after ccimp.com in the BestRef global ranking of the most important sources of Wikipedia.